for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

AstraZeneca plc (ADR)

AZN.N

Latest Trade

48.91USD

Change

-0.25(-0.51%)

Volume

449,021

Today's Range

48.76

 - 

49.86

52 Week Range

48.17

 - 

58.07

As of on the NASDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
49.16
Open
49.86
Volume
449,021
3M AVG Volume
248.18
Today's High
49.86
Today's Low
48.76
52 Week High
58.07
52 Week Low
48.17
Shares Out (MIL)
1,312.70
Market Cap (MIL)
131,877.40
Forward P/E
20.16
Dividend (Yield %)
2.79

Next Event

AstraZeneca PLC Virtual Roadshow - Asia Pacific

Latest Developments

More

Novavax Expects To Start Pediatric Studies For Its Covid-19 Vaccine In Spring

Astrazeneca To Withdraw Imfinzi U.S. Indication For Advanced Bladder Cancer

AstraZeneca Says Enhertu Authorised In UK For Treatment Of HER2 Positive Metastatic Breast Cancer

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About AstraZeneca plc (ADR)

AstraZeneca PLC is a biopharmaceutical company. It focuses on discovery and development of products, which are then manufactured, marketed and sold. It focuses on three main therapy areas: Oncology, Cardiovascular, Renal & Metabolic (CVRM) and Respiratory, while selectively pursuing therapies in Autoimmunity, Infection and Neuroscience. In CVRM, it is expanding its portfolio into the cardiovascular-renal area with roxadustat, as well as investing to explore the benefits of its SGLT2 and GLP-1 franchises in chronic kidney disease (CKD) and heart failure (HF). It has approximately 38 projects in Phase I, including 26 new molecular entities (NMEs), and 12 oncology combination projects. It has approximately 43 projects in Phase II, including 25 NMEs; six additional indications for projects that have reached phase II, and 12 oncology combination projects. It has approximately 22 projects in late-stage development, either in Phase III/pivotal Phase II studies or under regulatory review.

Industry

Biotechnology & Drugs

Contact Info

1 Francis Crick Avenue

CB2 0AA

United Kingdom

+44.20.73045000

https://www.astrazeneca.com/Home

Executive Leadership

Leif Johansson

Independent Non-Executive Chairman of the Board

Pascal Soriot

Chief Executive Officer, Executive Director

Marc Dunoyer

Chief Financial Officer, Executive Director

Jeffrey A. Pott

Chief Human Resource Officer, General Counsel

Katarina Ageborg

Executive Vice President - Sustainability, Chief Compliance Officer

Key Stats

1.60 mean rating - 5 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2018

22.1K

2019

24.4K

2020

26.6K

2021(E)

32.4K
EPS (USD)

2018

1.730

2019

1.750

2020

2.010

2021(E)

2.485
Price To Earnings (TTM)
41.16
Price To Sales (TTM)
4.95
Price To Book (MRQ)
8.42
Price To Cash Flow (TTM)
21.83
Total Debt To Equity (MRQ)
130.46
LT Debt To Equity (MRQ)
115.18
Return on Investment (TTM)
7.13
Return on Equity (TTM)
4.91

Latest News

Latest News

South Korea kicks off COVID-19 vaccination campaign

South Korea launched its COVID-19 inoculation campaign on Friday, with shots to be administered in some 200 nursing homes, in a campaign that officials call the first step in returning the country to more normal life.

South Korea kicks off COVID-19 vaccination campaign - Reuters TV

South Korea launched its COVID-19 inoculation campaign on Friday by administering AstraZeneca's vaccines to nursing home workers and patients across the country.

Macron says he would take AstraZeneca vaccine if it was offered

French President Emmanuel Macron said on Thursday he would gladly accept being inoculated with the Oxford/AstraZeneca COVID-19 vaccine if it were offered when his turn comes.

Under fire in EU, AstraZeneca CEO says "hopefully" will meet vaccine supply goals

AstraZeneca boss Pascal Soriot said on Thursday he hoped to meet the European Union's expectations on the number of COVID-19 vaccines the company can deliver to the bloc in the second quarter, after big cuts in the first three months of the year.

AstraZeneca chief says company hopes to catch up, meet EU's Q2 COVID-19 vaccine supply targets

AstraZeneca's Chief Executive Pascal Soriot said on Thursday he hoped to meet the European Union's expectations on the number of COVID-19 vaccines the company can deliver to the bloc in the second quarter of the year.

AstraZeneca CEO 'confident' COVID-19 vaccine yield will increase in Q2

AstraZeneca's Chief Executive Pascal Soriot said on Thursday he is "confident" yields in its COVID-19 vaccine will increase in the second quarter, as the company aims to boost European Union supplies after big cuts in the first three months of the year.

AstraZeneca's chief confirms pledge of 40 million COVID-19 shots to EU in first quarter

AstraZeneca is trying to deliver 40 million doses of its COVID-19 vaccine to the EU by the end of March, less than half the amount it promised in its contract for the quarter, CEO Pascal Soriot told European lawmakers on Thursday.

Bahrain first to approve Johnson & Johnson COVID-19 vaccine for emergency use - regulator

Bahrain has approved Johnson & Johnson's one-dose COVID-19 vaccine for emergency use, the first country to do so, the National Health Regulatory Authority (NHRA) said on Thursday.

Bahrain first to approve Johnson & Johnson COVID-19 vaccine for emergency use: regulator

Bahrain has approved Johnson & Johnson's one-dose COVID-19 vaccine for emergency use, the first country to do so, the National Health Regulatory Authority (NHRA) said on Thursday.

Factbox: Latest on the worldwide spread of the coronavirus

European Union leaders will meet on Thursday to try to speed up the production and rollout of vaccines in a race against the emergence of new variants that some fear could bring a third wave of the pandemic across the continent.

AstraZeneca says it will have no vaccine supply shortfall in second quarter, EU wary

AstraZeneca will deliver 180 million COVID-19 vaccines to Europe in the second quarter, including 20 million to Italy, the head of its Italian unit was quoted as saying on Thursday, but EU officials remained wary about supply.

India's health workers balk at taking homegrown COVID-19 vaccine

India is struggling to convince its health and front-line workers to take a homegrown COVID-19 vaccine controversially approved without late-stage efficacy data, government data showed https://dashboard.cowin.gov.in on Thursday, days ahead of a wider roll-out.

Bulgaria accuses AstraZeneca of taking country's vaccine 'hope' away

Bulgaria's health minister has accused AstraZeneca of failing to stick to its delivery schedule of COVID-19 vaccines to the country and demanded the immediate shipment of at least 52,800 doses that were postponed to March 1.

Only 15% of AstraZeneca vaccine available in Germany has been used

Germany has administered only 15% of the AstraZeneca coronavirus shots it has available, the health ministry said, as the vaccine faces public resistance after trials showed it to be less effective than alternatives.

Vietnam's first batch of COVID-19 vaccine arrives from South Korea

Vietnam received the first batch of 117,000 doses of the AstraZeneca COVID-19 vaccine on Wednesday ahead of the planned rollout of the Southeast Asian country's immunisation programme from next month.

Vietnam says to secure 90 million COVID-19 vaccine doses this year

Vietnam aims to obtain 90 million COVID-19 vaccine doses this year, including 30 million through the WHO-led COVAX scheme, 30 million from AstraZeneca and the rest from negotiations with Pfizer, its health ministry said on Wednesday.

Upbeat German data lifts European shares; Puma, AstraZeneca weigh

European shares rose on Wednesday, supported by stronger-than-expected growth in Germany's economy, although concerns over a possible rise in inflation and lofty equity valuations kept gains in check.

Vietnam's first batch of COVID-19 vaccine arrives from South Korea

Vietnam received the first batch of 117,000 doses of the AstraZeneca COVID-19 vaccine on Wednesday ahead of the planned rollout of the Southeast Asian country's vaccination programme from next month.

South Korea hails arrival of virus vaccines as first step in 'return to normal'

South Korea shipped its first doses of a coronavirus vaccine on Wednesday, transferring AstraZeneca vaccines from a production facility in the country to a warehouse outside the capital of Seoul in preparation for this week's inoculation drive.

Colombia approves emergency use of AstraZeneca coronavirus vaccine

Colombia has approved emergency use of AstraZeneca's coronavirus vaccine, the director of the food and drug regulator INVIMA said as part of a government address on Tuesday.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up